Novella Clinical Taps Medidata Solutions for Additional Insight into Clinical Research Costs
Medidata Solutions announced that Novella Clinical has expanded its use of Medidata products with the addition of Medidata Grants Manager®, the investigator site benchmarking tool. Grants Manager offers Novella a clear competitive advantage by enabling access to critical cost data to more accurately forecast trial costs as it serves sponsors outsourcing clinical trial activities. Grants Manager is designed to help users streamline site budget negotiations, ensure fair and reliable investigator payments, mitigate compliance risks, and reduce time of site enrollment.
Novella first partnered with Medidata in 2005 when it adopted Medidata Rave®, a system for electronic data capture, management, and analysis. Now, with the adoption of Grants Manager, Novella has access to Medidata’s unique PICAS® database—a clinical cost database derived from negotiated agreements between sponsors, investigators and CROs—which will bring insight into industry-benchmarked investigator site costs. Grants Manager offers access to data from nearly a quarter million grants and contracts and more than 27,000 protocols in over 1,400 indications.
As a Medidata Services Partner, Novella is accredited in Medidata Rave to provide a full suite of Rave-related services, including end-user training, user and site administration, study build, reporting, outputs, integrations, and migrations. The addition of Grants Manager into Novella’s clinical systems environment further enables it to provide services that streamline and enhance its customers’ clinical trials.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
